A dire text message made this doctor’s cancer research painfully real

Oncologist Scott Lippman has spent decades treating head and neck cancer patients and trying to understand how their tumors form. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by      When a dire text message interrupted his talk, this doctor’s cancer research became painfully real By Jonathan Wosen Oncologist Scott Lippman, who specializes in head and neck cancer, sits outside the Moores Cancer Center in La Jolla, Calif. (Sandy Huffaker for STAT) If you’d seen him, you wouldn’t have known Scott Lippman was living through one of the most harrowing days of his 35-year career. The veteran oncologist rushed home from a conference to welcome one of his patients — someone he had come to see as a friend — into his home to recover. “It just was the first time for me that my lives would converge or collapse,” Lippman said. “My work life, my patients, my research just all became very real.” Read More Sponsor content by asgct How to launch a start-up from a promising cell and gene therapy product There is often intriguing research or proof-of-concept data with a cell and gene therapy product that appears ready for development into a therapeutic. The challenge is how to form, finance, and build a company focused on the transition toward a first-in-human clinical trial. Learn how during this two-part symposium, Translating Science into Medicine: Moving from Bench to Startup during ASGCT’s 25th Annual Meeting, to gain an understanding of putting translational medicine into practice.  More great reads from STAT this week Biden’s new high-stakes research agency needs a home. For cities and states, the race for ARPA-H is on By Lev Facher For patients, seeing the benefits of the new, fully sequenced genome could take years By Megan Molteni Listen: How one 1910 report curtailed Black medical education for over a century By Nicholas St. Fleur ‘We need to be much more diverse’: More than half of data used in health care AI comes from the U.S. and China By Katie Palmer Hospital prices are soaring especially fast in Northern California. Here’s why By Tara Bannow ‘We don’t have a say’: Siobhan Wescott wants to elevate the voices of Native Americans in public health By Isabella Cueto Virtual reality in medicine is garnering more investment. Will the health care system buy in? By Mohana Ravindranath Opinion: The organ procurement system is failing people of color like me. It’s time for reform By LaQuayia Goldring A new crop of companies is reshaping the health data economy By Casey Ross Saturday, April 9, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser